Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2008
10/16/2008WO2008124724A1 Raav vector compositions having tyrosine-modified capsid proteins and methods for use
10/16/2008WO2008124526A1 Methods for transforming eukaryotic algae
10/16/2008WO2008124523A1 Butanol production by recombinant microorganisms
10/16/2008WO2008124495A2 Ahas mutants
10/16/2008WO2008124431A1 Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use
10/16/2008WO2008124331A1 Novel sequences and dna vaccines against avian flu
10/16/2008WO2008124194A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids
10/16/2008WO2008124192A2 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008124166A2 Fusion proteins of collagen-binding domain and parathyroid hormone
10/16/2008WO2008124162A2 Substrate-selective co-fermentation process
10/16/2008WO2008124133A1 Reprogramming of somatic cells
10/16/2008WO2008124119A1 Improved methods and compositions for determining the pathogenic status of infectious agents
10/16/2008WO2008124048A2 Multizymes and their use in making polyunsaturated fatty acids
10/16/2008WO2008123731A1 Gene involved in the biosynthesis of lycopene, recombinant vector comprising the gene, and transformed microorganism with the recombinant vector
10/16/2008WO2008123714A1 A method for producing a hybrid seed using plant of novel cytoplasmic-genic male sterility raphanus sativus line and dna markers for selecting the plant of said raphanus sativus line
10/16/2008WO2008123625A1 Method for activating receptor by cofactor and method for utilizing ligand activity
10/16/2008WO2008123622A1 Modified microorganism
10/16/2008WO2008123610A1 Long-time monitoring method using photoprotein and analysis method
10/16/2008WO2008123607A1 Method for production of dipeptide
10/16/2008WO2008123538A1 Method for measurement of methylation in dna
10/16/2008WO2008123537A1 Method for measurement of methylation in dna
10/16/2008WO2008123390A1 Production of curcuminoid using novel polyketide synthase
10/16/2008WO2008123308A1 Therapeutic agent comprising vasohibin
10/16/2008WO2008123266A1 Target protein and target gene for drug discovery, and screening method
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008123202A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR
10/16/2008WO2008123180A1 Method for detection of target substance, and tag, dna, vector, probe and detection kit for use in the method
10/16/2008WO2008123112A1 Nucleic acid detection cassette and nucleic acid detection apparatus
10/16/2008WO2008123019A1 Method of detecting change in gene and detection device
10/16/2008WO2008122886A2 Transgenic non-human mammal with homodimeric vh binding complex
10/16/2008WO2008122811A2 Adenoviral vectors encoding a pathogen or tumour antigen
10/16/2008WO2008122794A2 Breast cancer methods, medicaments and agents
10/16/2008WO2008122770A2 Nucleic acids and libraries for use in functional analysis of regulatory rnas such as micrornas (mirnas)
10/16/2008WO2008122769A2 Adenoviral vector encoding malaria antigen
10/16/2008WO2008122666A1 Inhibitors of mrp4 for the treatment of vascular disorders
10/16/2008WO2008122618A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/16/2008WO2008122604A1 Method of crosslinking two objects of interest
10/16/2008WO2008122598A2 Respiratory syncytial virus (rsv) viral load detection assay
10/16/2008WO2008122551A2 Anti-epcam antibody and uses thereof
10/16/2008WO2008122500A1 Method for purifying biomolecules
10/16/2008WO2008122449A1 Method of producing a resistant starch
10/16/2008WO2008122441A2 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/16/2008WO2008122406A1 Insect resistant cotton plants and methods for identifying same
10/16/2008WO2008122354A1 Vector with codon-optimised genes for an arabinose metabolic pathway for arabinose conversion in yeast for ethanol production
10/16/2008WO2008122314A1 Rna interference tags
10/16/2008WO2008122097A1 Synthesis of standards for detection and quantification of nucleic acids and kit
10/16/2008WO2008122084A1 Nucleic acid enzymes and complexes and methods for their use
10/16/2008WO2008104184A3 Method for cloning cognate antibodies
10/16/2008WO2008103993A3 Compositions and methods for treating glycogen storage diseases
10/16/2008WO2008100922A3 Methods and compositions related to prefoldin and its regulation
10/16/2008WO2008099178A3 Binding members for ige molecules
10/16/2008WO2008097619A3 Variant buttiauxella sp. phytases having altered properties
10/16/2008WO2008097328A3 Asymmetric functionalized nanoparticles and methods of use
10/16/2008WO2008091888A3 Novel gene disruptions, compositions and methods relating thereto
10/16/2008WO2008091284A9 Vectors for inducing homozygous mutations and methods of using same
10/16/2008WO2008089440A3 Compositions and methods for detecting, treating, or preventing reductive stress
10/16/2008WO2008089438A3 A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions
10/16/2008WO2008089394A3 Mycobacterium tuberculosis persistance genes
10/16/2008WO2008088839A9 Methods of isolating and purifying nucleic acid-binding biomolecules and compositions including same
10/16/2008WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof
10/16/2008WO2008083969A3 Differential expression of subgenome specific alleles in cotton and uses thereof
10/16/2008WO2008079372A9 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/16/2008WO2008076857A3 Method and compositions for inhibiting mage protein interaction with kap-1
10/16/2008WO2008076835A3 Generation of plants with altered oil, protein, or fiber content
10/16/2008WO2008060483A3 Protein-protein interaction biosensors and methods of use thereof
10/16/2008WO2008060357A3 Methods of polypeptide production
10/16/2008WO2008054770A3 Use of tumor necrosis factor-alpha p75 receptor for the reduction of inflammation
10/16/2008WO2008048653A3 Seashore paspalum cultivar named 'te-13'
10/16/2008WO2008045489A3 Glucoamylase variants with altered properties
10/16/2008WO2008045148A3 Protease screening methods and proteases identified thereby
10/16/2008WO2008028946A3 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
10/16/2008WO2008027899A3 Methods and compositions related to apobec-1 expression
10/16/2008WO2008014296A3 Composition and method for treatment of tumors
10/16/2008WO2008011234A3 Recombinant host for producing l-asparaginase ii
10/16/2008WO2008011107A3 Antagonists of protease activated receptor-1 (par1)
10/16/2008WO2008008276A3 Tetracycline repressor regulated oncolytic viruses
10/16/2008WO2008002673A3 Cell-free synthesis of virus like particles
10/16/2008WO2007146003A3 Methods for ester detoxication
10/16/2008WO2007140195A3 Methods and systems for increasing production of equilibrium reactions
10/16/2008WO2007139982A3 Methods and compositions for gene inactivation
10/16/2008WO2007127912A3 Thermostable cellulase and methods of use
10/16/2008WO2007127835A3 Optimization of coronatine production in a genetically improved strain of pseudomonas syringae
10/16/2008WO2007123777A3 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
10/16/2008WO2007117682A3 Mature dendritic cell compositions and methods for culturing same
10/16/2008WO2007115230A3 A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells
10/16/2008WO2007095336A3 Production of hiv
10/16/2008WO2007094924A3 Human telomerase reverse transcriptase peptides
10/16/2008WO2007092704A8 Genes for enhancing nitrogen utilization efficiency in crop plants
10/16/2008WO2007089873A3 Fermentation process for continuous plasmid dna production
10/16/2008WO2007012944A9 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/16/2008WO2006105436A3 Cloning and characterization of micrornas from rice
10/16/2008WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/16/2008WO2006036613A3 Mracs as modifiers of the rac pathway and methods of use
10/16/2008US20080256670 AtRSp gene promoters
10/16/2008US20080256668 Non-Transgenic Herbicide Resistant Plants
10/16/2008US20080256667 Using mechanical disruption and vector transformation to generate transgenic embryonic meristem explants
10/16/2008US20080256666 Using increased ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) activity as reporter function indicating regenerated photosynthetic and production processes in plants
10/16/2008US20080256664 Means and Method for Modifying the Biomass of Plants
1 ... 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 ... 4023